9 completed, 2 recruiting, 2 terminated, 1 withdrawn. 4 Not applicable, 4 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Terminated 1, Withdrawn 1 |
| Phase 2 | 4 | Completed 3, Terminated 1 |
| Phase 3 | 1 | Recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Desensitization, Immunologic: new trials by email Literature Review of Desensitization, Immunologic trials Research Report on Desensitization, Immunologic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df Allergen Immunotherapy Extract - Rhinitis, Rhinoconjunctivitis | Phase 3 | Recruiting | Inmunotek S.L. | 736 | 2025-04-02 | 2026-01-16 |
| Long Term Effect of AIT in Children Allergen Immunotherapy Extract - Allergy in Children | Recruiting | Odense University Hospital | 100 | 2024-05-01 | 2026-10-19 | |
| Changes in Eosinophil Cationic Protein and Sputum Eosinophils Following Allergen Immunotherapy Allergen Immunotherapy Extract - Allergic Asthma | Not applicable | Completed | Mansoura University Hospital | 100 | 2023-01-01 | 2026-08-18 |
| Efficacy of Sublingual Versus Subcutaneous Allergen Immunotherapy in Patients With Bronchial Asthma Allergen Immunotherapy Extract - Efficacy, Self | Not applicable | Completed | Mansoura University Hospital | 100 | 2021-10-20 | 2023-03-28 |
| Study to Evaluate the Efficacy and Safety of "Allergovac Poliplus" in Polysensitized Patients With Allergic Rhinitis/Rhinoconjunctivitis, With or Without Asthma Allergen Immunotherapy (AIT) - Rhinitis, Allergic, Rhinoconjunctivitis | Completed | Roxall Medicina España S.A | 122 | 2018-08-30 | 2021-10-20 | |
| A Novel Biologic Therapy for Perennial Allergic Rhinitis Allergen Immunotherapy Extract, Allergen Immunotherapy Control - Allergic Rhinitis | Phase 2 | Completed | Johns Hopkins University | 31 | 2016-12-19 | 2019-09-04 |
| CBT-I for Cannabis Use Cognitive Behavioral Therapy for Insomnia (CBT-I), Cognitive Behavioral Therapy for Insomnia Plus Mobile App (CBT-I-MA), Desensitization Treatment for Insomnia - Marijuana Abuse, Sleep Initiation and Maintenance Disorders | Not applicable | Terminated | VA Office of Research and Development | 111 | 2014-11-03 | 2019-08-28 |
| Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study Grazax, Grazax Placebo - Allergic Rhinitis | Phase 2 | Completed | Imperial College London | 46 | 2013-09-01 | 2019-12-04 |
| The Efficacy & Safety of the UAS Immunotherapy Protocol allergen immunotherapy - Perennial Allergic Rhinitis With Seasonal Variation | Completed | United Allergy Services | 60 | 2012-04-01 | 2012-10-04 | |
| Helping Veterans Quit Smoking by Improving Their Sleep Integrated Care, Cognitive-Behavioral Treatment for Insomnia, Desensitization Treatment for Insomnia - Smoking | Phase 2 | Terminated | US Department of Veterans Affairs | 142 | 2011-10-01 | 2014-12-02 |
| The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis Allergen immunotherapy - Allergic Asthma, Allergic Rhinitis | Completed | Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C. | 17 | 2008-01-01 | 2015-10-29 | |
| Promoting Tolerance to Common Allergens in High-Risk Children: Global Prevention of Asthma in Children (GPAC) Study Oral mucosal immunoprophylaxis (OMIP), Placebo - Asthma, Allergic Sensitization | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 51 | 2006-05-01 | 2017-05-01 |
| Maintenance Bee-Venom Immunotherapy Administered at 6-Month Intervals Does Not Protect Against re-Stings venom immunotherapy - Venom Allergy | Phase 4 | Completed | Meir Medical Center | 60 | 2004-06-01 | 2008-05-26 |
| Allergy Immunotherapy in the Management of Eosinophilic Esophagitis Allergy immunotherapy ("allergy shots") - Eosinophilic Esophagitis | Not applicable | Withdrawn | United States Naval Medical Center, San Diego | 2016-08-19 |
Rhinitis, Allergic (7) · Asthma (2) · Rhinitis (2) · Dermatitis, Atopic (1) · Dust Mite Allergy (1) · Eczema (1) · Eosinophilic Esophagitis (1) · Food Hypersensitivity (1) · Marijuana Abuse (1) · Rhinitis, Allergic, Seasonal (1) · Sleep Initiation and Maintenance Disorders (1) · Smoking (1) · Venom Hypersensitivity (1)
Mansoura University Hospital (2) · Imperial College London (1) · Inmunotek S.L. (1) · Johns Hopkins University (1) · Meir Medical Center (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Odense University Hospital (1) · Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C. (1) · Roxall Medicina España S.A (1) · US Department of Veterans Affairs (1) · United Allergy Services (1) · United States Naval Medical Center, San Diego (1) · VA Office of Research and Development (1)
United States (6) · Egypt (2) · Spain (2) · Argentina (1) · Australia (1) · China (1) · Denmark (1) · Portugal (1) · United Kingdom (1)
Arnon Goldberg, M.D (1) · Frederick M Schaffer, M.D. (1) · Josefine Gradman, PhD (1) · Kimberly A Babson, PhD MA BS (1) · Michele Columbo, M.D. (1) · Mohamed A Elmoniem (1) · Mohamed AbdElmoniem (1) · Patrick Holt, MD (1) · Peter Sly, MD (1) · Raquel Caballero (1) · Stephen R Durham, Prof. (1) · Steven H. Woodward, PhD (1)
PMID 11842305, PMID 17944807, PMID 20100188, PMID 20523122, PMID 23768574, PMID 26682038, PMID 27895895